All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
Monoclonal B-cell lymphocytosis (MBL) is a pre-leukemic form of chronic lymphocytic leukemia (CLL), characterized by a clonal B-cell presence in the absence of clinical symptoms and organ involvement, with < 5000 monoclonal B lymphocytes/µl in peripheral blood. Approximately 1−2% of patients with MBL progress to CLL, annually.